Financial Ratios

LYKA LABS LTD.

NSE : LYKALABSBSE : 500259ISIN CODE : INE933A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE105.95-1.85 (-1.72 %)
PREV CLOSE ( ) 107.80
OPEN PRICE ( ) 106.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11996
TODAY'S LOW / HIGH ( )105.20 109.30
52 WK LOW / HIGH ( )89 143.5
NSE106.10-1.45 (-1.35 %)
PREV CLOSE( ) 107.55
OPEN PRICE ( ) 106.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 72495
TODAY'S LOW / HIGH( ) 105.65 108.95
52 WK LOW / HIGH ( )88.5 144.3
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-4.3313.91-5.04-19.310.62
   CEPS(Rs)0.0719.27-2.23-16.602.19
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)19.2215.491.546.5534.77
   Tax Rate(%)-0.5933.7621.40-0.43124.41
Margin Ratios
   Core EBITDA Margin(%)19.3659.3223.17-7.892.21
   EBIT Margin(%)-2.0348.7811.50-88.70-3.32
   Pre Tax Margin(%)-16.3936.65-29.54-135.36-17.24
   PAT Margin (%)-16.4924.28-23.22-135.944.21
   Cash Profit Margin (%)0.2933.64-10.29-116.8814.99
Performance Ratios
   ROA(%)-6.8619.67-7.12-24.760.72
   ROE(%)-25.69163.37-124.71-94.981.79
   ROCE(%)-1.0247.254.45-20.89-0.70
   Asset Turnover(x)0.420.810.310.180.17
   Sales/Fixed Asset(x)0.500.980.410.350.44
   Working Capital/Sales(x)6.54-3.54-3.17-1.65-2.14
Efficiency Ratios
   Fixed Capital/Sales(x)2.021.022.442.872.28
   Receivable days78.6930.5248.35162.49265.62
   Inventory Days34.2513.8629.3352.1958.69
   Payable days106.20122.42221.30358.60356.33
Valuation Parameters
   PER(x)0.009.750.000.0039.78
   PCE(x)1398.287.04-11.64-0.7711.17
   Price/Book(x)5.458.7516.921.950.70
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)4.773.063.694.053.90
   EV/Core EBITDA(x)20.165.0113.81-266.4644.92
   EV/EBIT(x)-234.466.2732.11-4.57-117.40
   EV/CE(x)2.152.411.170.790.67
   M Cap / Sales3.992.371.200.901.67
Growth Ratio
   Net Sales Growth(%)-50.96163.9652.82-1.07-1.20
   Core EBITDA Growth(%)-80.99502.432785.81-117.32160.06
   EBIT Growth(%)-102.041019.97119.81-2541.1860.48
   PAT Growth(%)-133.30375.9773.89-3295.99115.99
   EPS Growth(%)-131.13375.9773.89-3234.73115.99
Financial Stability Ratios
   Total Debt/Equity(x)1.212.9036.687.290.94
   Current Ratio(x)1.410.500.570.550.72
   Quick Ratio(x)1.250.420.470.460.64
   Interest Cover(x)-0.144.020.28-1.90-0.24
   Total Debt/Mcap(x)0.220.332.173.741.33

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.